Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02658214
Brief Title: Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

First Submitted : January 11, 2016
First Submitted that Met QC Criteria : January 14, 2016
First Posted : January 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 19, 2020
Last Update Posted : August 20, 2020